Prior to joining Care Capital, Mr. Markham was the Vice Chairman of the Management Board and COO of Aventis. Previously he was the CEO of Aventis Pharma, the CEO of Hoechst Marion Roussel, and the President and COO of Marion Merrell Dow, Inc. and a member of its board of directors.

From 1973 to 1993, Mr. Markham was associated with Merck & Co., Inc., culminating in his position as President and COO. Prior to this role, Mr. Markham held a number of positions, starting as a professional representative and then becoming district manager, product manager and director, executive director and then VP of Marketing for the Merck Sharp & Dohme Division. He later was responsible for Merck’s European pharmaceutical business before being named Senior Vice President of Merck & Co. and President of the Merck Human Health Division, responsible for worldwide marketing and sales of Merck’s pharmaceutical products.

Mr. Markham received a B.S. in Pharmacy and Pharmacal Sciences from Purdue University and has served as a member of the Dean’s Advisory Council of the university. He has also been awarded an honorary Doctor of Science degree, the university’s highest honor for achievement.

Mr. Markham has been a member of the board of directors and executive committee of the Pharmaceutical Research and Manufacturers Association, a member of the Board of Trustees of the HealthCare Institute of New Jersey, and a member of the board of directors of Aventis Pasteur and of Commerce Bank of Kansas City.